DOI: 10.32098/mltj_2026_6760

Differentiation of distal myopathies using muscular magnetic resonance imaging: A systematic review

Authors

  • Negin Rahimi School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Nastaran Maghbouli Department of Physical Medicine and Rehabilitation, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Fatemeh Ghasemi School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Nesa Milan Department of Orthopedic Surgery, University of California, San Francisco, USA
  • Saeed Pourhassan Department of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

nmaghbouli@sina.tums.ac.ir

Keywords

Distal myopathy, magnetic resonance imaging, MRI scan, mutation, myopathy

Abstract

Objectives: Diagnosis of distal myopathies is challenging. Muscle magnetic resonance imaging (MRI) is an increasingly recognized tool for diagnosis and follow-up of muscle diseases. Given the rarity of these diseases, the unique MRI pattern of their muscle involvement remains unclear.
Materials and methods: We conducted a comprehensive search in PubMed, Scopus, and Google Scholar Library to identify English-language case reports and case series studies of different myopathies published between January 2000 and September 2024. The type of gene mutation in patients, their MRI findings, including regions imaged, muscles involved and spared, and the Mercuri scoring system for assessing the fat infiltration, were extracted from the studies.
Results: Thirty-four studies consisting of 6 mutations were analyzed. The tibialis anterior was the most severely compromised muscle in myosin heavy chain-7 (MYH7), titin (TTN), glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE), and dysferlin (DYSF) mutations. Extensor digitorum was in second place in TTN-associated myopathy. Hamstring muscles and gastrocnemius medial heads were moderately affected in GNE and DYSF cases, while vastus muscles and calf muscles were severely involved in adenylosuccinate synthase 1-related myopathies (ADSSL1). In matrin-3 (MATR3) mutation cases, the gastrocnemius and semimembranous muscles had the most pronounced fat infiltration.
Conclusion: We defined unique patterns for different myopathies that can be implemented in the initial clinical assessment of patients with distal myopathy. We advise further studies with a larger number of patients.

View the entire article

Downloads

References

  1. Udd B. Chapter 30 - The distal myopathies. In: Rosenberg RN, Pascual JM, editors. Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease (Seventh Edition): Academic Press; 2025. p. 589-600.
  2. Udd B. Distal myopathies – New genetic entities expand diagnostic challenge. Neuromuscular Disorders. 2012;22(1):5-12. doi: 10.1016/j.nmd.2011.10.003
  3. van Spaendonck-Zwarts KY, van Hessem L, Jongbloed JD, de Walle HE, Capetanaki Y, van der Kooi AJ, et al. Desmin-related myopathy. Clinical genetics. 2011;80(4):354-66. doi: 10.1111/j.1399-0004.2010.01512.x
  4. Pelin K, Hilpelä P, Donner K, Sewry C, Akkari PA, Wilton SD, et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proceedings of the National Academy of Sciences. 1999;96(5):2305-10. doi: 10.1073/pnas.96.5.2305
  5. Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-García R, Palmer J, et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2001;49(1):130-4. doi: 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0
  6. Pfeffer G, Elliott HR, Griffin H, Barresi R, Miller J, Marsh J, et al. Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain. 2012;135(6):1695-713. doi: 10.1093/brain/aws102.
  7. Oldfors A, Tajsharghi H, Darin N, Lindberg C. Myopathies associated with myosin heavy chain mutations. Acta Myologica: Myopathies and Cardiomyopathies: Official Journal of the Mediterranean Society of Myology. 2004;23(2):90-6.
  8. Carrillo N, Malicdan MC, Huizing M. GNE myopathy: etiology, diagnosis, and therapeutic challenges. Neurotherapeutics. 2018;15(4):900-14. doi:10.1007/s13311-018-0671-y
  9. Sifeddine N, Amalou G, Charif M, Nahili H, Bouzidi A, Salaheddine R, et al. GNE Myopathy and Duchenne Muscular Dystrophy in Two Moroccans Families. Muscles, Ligaments & Tendons Journal (MLTJ). 2023;13(4).
  10. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology. 2004;62(8):1363-71. doi: 10.1212/01.WNL.0000123576.74801.75
  11. Griggs RC. Overview of distal myopathies: from the clinical to the molecular. Neuromuscular Disorders. 1997;6(7):457-8. doi: 10.1016/S0960-8966(98)00030-3
  12. Savarese M, Sarparanta J, Vihola A, Jonson PH, Johari M, Rusanen S, et al. Panorama of the distal myopathies. Acta Myologica. 2020;39(4):245. doi: 10.36185/2532-1900-028
  13. Rochdi K, Barakat A, Saile R. Inherited myopathies in the Middle East and North Africa. Gene Reports. 2022;29:101674. doi: 10.1016/j.genrep.2022.101674
  14. Nishino I, Carrillo-Carrasco N, Argov Z. GNE myopathy: current update and future therapy. J Neurol Neurosurg Psychiatry. 2015;86(4):385-92. doi: 10.1136/jnnp-2013-307051
  15. Mensch A, Kraya T, Koester F, Müller T, Stoevesandt D, Zierz S. Whole-body muscle MRI of patients with MATR3-associated distal myopathy reveals a distinct pattern of muscular involvement and highlights the value of whole-body examination. J Neurol. 2020;267(8):2408-20. doi: 10.1007/s00415-020-09862-9
  16. Bugiardini E, Khan AM, Phadke R, Lynch DS, Cortese A, Feng L, et al. Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre. Neuromuscular Disorders. 2019;29(10):747-57. doi: 10.1016/j.nmd.2019.08.003
  17. Sevy A, Cerino M, Gorokhova S, Dionnet E, Mathieu Y, Verschueren A, et al. Improving molecular diagnosis of distal myopathies by targeted next-generation sequencing. Journal of Neurology, Neurosurgery & Psychiatry. 2016;87(3):340-2. doi: 10.1136/jnnp-2014-309663
  18. Bugiardini E, Morrow JM, Shah S, Wood CL, Lynch DS, Pitmann AM, et al. The diagnostic value of MRI pattern recognition in distal myopathies. Frontiers in neurology. 2018;9:456. doi: 10.3389/fneur.2018.00456
  19. Chardon JW, Díaz-Manera J, Tasca G, Bönnemann CG, Gómez-Andrés D, Heerschap A, et al. MYO-MRI diagnostic protocols in genetic myopathies. Neuromuscular Disorders. 2019;29(11):827-41. doi: 10.1016/j.nmd.2019.08.011
  20. Kalia V, Leung DG, Sneag DB, Del Grande F, Carrino JA, editors. Advanced MRI techniques for muscle imaging. Seminars in musculoskeletal radiology; 2017: Thieme Medical Publishers.
  21. Venturelli N, Tordjman M, Ammar A, Chetrit A, Renault V, Carlier RY. Contribution of muscle MRI for diagnosis of myopathy. Revue Neurologique. 2023;179(1):61-80. doi: 10.1016/j.neurol.2022.12.002
  22. Barohn RJ, Dimachkie MM, Jackson CE. A pattern recognition approach to patients with a suspected myopathy. Neurol Clin. 2014;32(3):569-93, vii. doi: 10.1016/j.ncl.2014.04.008
  23. Lovitt S, Marden FA, Gundogdu B, Ostrowski ML. MRI in myopathy. Neurologic Clinics. 2004;22(3):509-38. doi: 10.1016/j.ncl.2004.03.008
  24. Lovitt S, Moore SL, Marden FA. The use of MRI in the evaluation of myopathy. Clinical Neurophysiology. 2006;117(3):486-95. doi: 10.1016/j.clinph.2005.10.010
  25. Kriss A, Jenkins T. Muscle MRI in motor neuron diseases: a systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2022;23(3-4):161-75. doi: 10.1080/21678421.2021.1936062
  26. Wasserman PL, Way A, Baig S, Gopireddy DR. MRI of myositis and other urgent muscle-related disorders. Emergency Radiology. 2021;28(2):409-21. doi: 10.1007/s10140-020-01866-2
  27. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews. 2015;4:1-9. doi: 10.1186/2046-4053-4-1
  28. Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine. 2007;25(2):433-40. doi: 10.1002/jmri.20804
  29. Perry L, Stimpson G, Singh L, Morrow J, Shah S, Baranello G, et al. Muscle magnetic resonance imaging involvement patterns in nemaline myopathies. Annals of clinical and translational neurology. 2023;10. doi: 10.1002/acn3.51816
  30. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case report guideline development. Journal of Dietary supplements. 2013;10(4):381-90.
  31. Pogoryelova O, González Coraspe JA, Nikolenko N, Lochmüller H, Roos A. GNE myopathy: from clinics and genetics to pathology and research strategies. Orphanet J Rare Dis. 2018;13(1):70. doi: 10.1186/s13023-018-0802-x
  32. Mullen J, Alrasheed K, Mozaffar T. GNE myopathy: History, etiology, and treatment trials. Front Neurol. 2022;13:1002310. doi: 10.3389/fneur.2022.1002310
  33. Tasca G, Ricci E, Monforte M, Laschena F, Ottaviani P, Rodolico C, et al. Muscle imaging findings in GNE myopathy. Journal of Neurology. 2012;259(7):1358-65. doi: 10.1007/s00415-011-6357-6
  34. Liu CY, Yao J, Kovacs WC, Shrader JA, Joe G, Ouwerkerk R, et al. Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy. Neurology. 2021;96(5):e798-e808. doi: 10.1212/wnl.0000000000011231
  35. Bouchard C, Tremblay JP. Portrait of Dysferlinopathy: Diagnosis and Development of Therapy. J Clin Med. 2023;12(18). doi: 10.3390/jcm12186011
  36. Bardakov SN, Tsargush VA, Carlier PG, Nikitin SS, Kurbatov SA, Titova AA, et al. Magnetic resonance imaging pattern variability in dysferlinopathy. Acta Myol. 2021;40(4):158-71. doi: 10.36185/2532-1900-059
  37. Jin S, Du J, Wang Z, Zhang W, Lv H, Meng L, et al. Heterogeneous characteristics of MRI changes of thigh muscles in patients with dysferlinopathy. Muscle Nerve. 2016;54(6):1072-9. doi: 10.1002/mus.25207.
  38. Fanin M, Angelini C. Progress and challenges in diagnosis of dysferlinopathy. Muscle & nerve. 2016;54(5):821-35. doi: 10.1002/mus.25367
  39. Tasca G, Ricci E, Penttilä S, Monforte M, Giglio V, Ottaviani P, et al. New phenotype and pathology features in MYH7-related distal myopathy. Neuromuscular Disorders. 2012;22(7):640-7. doi: 10.1016/j.nmd.2012.03.003
  40. Fiorillo C, Astrea G, Savarese M, Cassandrini D, Brisca G, Trucco F, et al. MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients. Orphanet Journal of Rare Diseases. 2016;11(1):91. doi: 10.1186/s13023-016-0476-1
  41. Dabaj I, Carlier RY, Gómez-Andrés D, Neto OA, Bertini E, D’amico A, et al. Clinical and imaging hallmarks of the MYH7-related myopathy with severe axial involvement. Muscle & nerve. 2018;58(2):224-34. doi: 10.1002/mus.26137
  42. Savarese M, Sarparanta J, Vihola A, Udd B, Hackman P. Increasing Role of Titin Mutations in Neuromuscular Disorders. J Neuromuscul Dis. 2016;3(3):293-308. doi:10.3233/jnd-160158
  43. Kellermayer D, Smith JE, 3rd, Granzier H. Titin mutations and muscle disease. Pflugers Arch. 2019;471(5):673-82. doi: 10.1007/s00424-019-02272-5
  44. Yu M, Zhu Y, Xie Z, Zheng Y, Xiao J, Zhang W, et al. Novel TTN mutations and muscle imaging characteristics in congenital titinopathy. Ann Clin Transl Neurol. 2019;6(7):1311-8. doi: 10.1002/acn3.50831
  45. Oates EC, Jones KJ, Donkervoort S, Charlton A, Brammah S, Smith JE, 3rd, et al. Congenital Titinopathy: Comprehensive characterization and pathogenic insights. Ann Neurol. 2018;83(6):1105-24. doi: 10.1002/ana.25241
  46. Iradi MCG, Triplett JC, Thomas JD, Davila R, Crown AM, Brown H, et al. Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy. Sci Rep. 2018;8(1):4049. doi: 10.1038/s41598-018-21371-4
  47. Ward C, Pandey UB. Matrin-3 dysfunction in myopathy and motor neuron degeneration. Neural Regen Res. 2022;17(3):575-6. doi: 10.4103/1673-5374.320986
  48. Baskar D, Polavarapu K, Preethish-Kumar V, Vengalil S, Nashi S, Töpf A, et al. Childhood-Onset Myopathy With Preserved Ambulation Caused by a Recurrent ADSSL1 Missense Variant. Neurol Genet. 2024;10(1):e200122. doi: 10.1212/nxg.0000000000200122
  49. Mroczek M, Durmus H, Bijarnia-Mahay S, Töpf A, Ghaoui R, Bryen S, et al. Expanding the disease phenotype of ADSSL1-associated myopathy in non-Korean patients. Neuromuscul Disord. 2020;30(4):310-4. doi: 10.1016/j.nmd.2020.02.006
  50. Park HJ, Shin HY, Kim S, Kim SH, Lee Y, Lee JH, et al. Distal myopathy with ADSSL1 mutations in Korean patients. Neuromuscul Disord. 2017;27(5):465-72. doi: 10.1016/j.nmd.2017.02.004
  51. Ranta-Aho J, Johari M, Udd B. Current advance on distal myopathy genetics. Curr Opin Neurol. 2024;37(5):515-22. doi: 10.1097/wco.0000000000001299
  52. Savarese M, Sarparanta J, Vihola A, Jonson PH, Johari M, Rusanen S, et al. Panorama of the distal myopathies. Acta Myol. 2020;39(4):245-65. doi: 10.36185/2532-1900-028

Published

2026-04-13

How to Cite

1.
Rahimi N, Maghbouli N, Ghasemi F, Milan N, Pourhassan S. Differentiation of distal myopathies using muscular magnetic resonance imaging: A systematic review. MLTJ [Internet]. 2026 Apr. 13 [cited 2026 Nov. 20];16. Available from: https://mltj.online/index.php/mltj/article/view/6760